Download references

Open Access Highly Accessed Open Badges

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Pablo Ureña-Torres*, Dominique Prié, Karim Keddad, Peter Preston, Paul Wilde, Hong Wan and J Brian Copley

BMC Nephrology 2014, 15:71  doi:10.1186/1471-2369-15-71